Last reviewed · How we verify
Ketoprofen Control - Ketoprofen Only
At a glance
| Generic name | Ketoprofen Control - Ketoprofen Only |
|---|---|
| Also known as | Orudis |
| Sponsor | University of Minnesota |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
- Inadequate Regional Anesthesia
- Headache
Key clinical trials
- Ketamine Administration for Postoperative Pain Management in Patients Undergoing Knee Arthroplasty (NA)
- Helping Osteoarthritis Patients to Walk With NSAID (PHASE4)
- Chest Wall Block After Sternotomy: Randomized Controlled Trial in Cardiac Surgery: (PABLOS Study) (PHASE3)
- A Study to Assess Efficacy and Tolerability of Ketoprofen 40 mg Granules vs Placebo (PHASE3)
- LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients (PHASE1)
- Opioid Free Anesthesia in Thoracic Surgery (NA)
- The Impact of Regional Anaesthesia on Hormone Levels in Thoracic Surgery.
- IV NSAI Versus Nebulized Morphine Analgesia for First-line Renal Colic (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ketoprofen Control - Ketoprofen Only CI brief — competitive landscape report
- Ketoprofen Control - Ketoprofen Only updates RSS · CI watch RSS
- University of Minnesota portfolio CI